JP2023532170A5 - - Google Patents
Info
- Publication number
- JP2023532170A5 JP2023532170A5 JP2022563209A JP2022563209A JP2023532170A5 JP 2023532170 A5 JP2023532170 A5 JP 2023532170A5 JP 2022563209 A JP2022563209 A JP 2022563209A JP 2022563209 A JP2022563209 A JP 2022563209A JP 2023532170 A5 JP2023532170 A5 JP 2023532170A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- infection
- coronavirus
- rsv
- individual
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020901194A AU2020901194A0 (en) | 2020-04-15 | Method of prophylaxis of coronavirus infection | |
| AU2020901194 | 2020-04-15 | ||
| AU2020902993A AU2020902993A0 (en) | 2020-08-21 | Method of prophylaxis of coronavirus infection | |
| AU2020902993 | 2020-08-21 | ||
| AU2020904246 | 2020-11-17 | ||
| AU2020904246A AU2020904246A0 (en) | 2020-11-17 | Method of prophylaxis of respiratory syncytial virus infection | |
| PCT/AU2021/050333 WO2021207790A1 (en) | 2020-04-15 | 2021-04-14 | Method of prophylaxis of coronavirus and/or respiratory syncytial virus infection |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023532170A JP2023532170A (ja) | 2023-07-27 |
| JP2023532170A5 true JP2023532170A5 (cg-RX-API-DMAC10.html) | 2024-04-22 |
| JP7869752B2 JP7869752B2 (ja) | 2026-06-03 |
Family
ID=78083455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022563209A Active JP7869752B2 (ja) | 2020-04-15 | 2021-04-14 | コロナウイルス及び/又は呼吸器合胞体ウイルス感染症の予防の方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230330134A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3930730A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP7869752B2 (cg-RX-API-DMAC10.html) |
| CN (1) | CN116056714A (cg-RX-API-DMAC10.html) |
| AU (2) | AU2021204697B1 (cg-RX-API-DMAC10.html) |
| GB (3) | GB2605247B (cg-RX-API-DMAC10.html) |
| SG (1) | SG11202112332VA (cg-RX-API-DMAC10.html) |
| WO (1) | WO2021207790A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022210132A1 (en) * | 2021-01-20 | 2023-08-31 | National University Corporation Hokkaido University | Anti-viral agent |
| CN114107223B (zh) * | 2021-11-25 | 2024-03-26 | 湖北省疾病预防控制中心(湖北省预防医学科学院) | 利用TPCK胰酶提高SARS-CoV-2病毒细胞培养滴度的方法 |
| CN113967211B (zh) * | 2021-12-15 | 2023-03-28 | 山东达因海洋生物制药股份有限公司 | 盐酸石蒜碱硫酯在制备抗冠状病毒药物中的应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPM623994A0 (en) * | 1994-06-15 | 1994-07-07 | Biomolecular Research Institute Limited | Antiviral dendrimers |
| AUPO104396A0 (en) * | 1996-07-17 | 1996-08-08 | Biomolecular Research Institute Limited | Antiviral linear polymers |
| AUPR412801A0 (en) | 2001-03-30 | 2001-05-03 | Starpharma Limited | Agent for the prevention and treatment of sexually transmitted disease s - I |
| GB2389530B (en) * | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| JP5213718B2 (ja) | 2005-10-18 | 2013-06-19 | スターファーマ・プロプライエタリー・リミテッド | 殺微生物性デンドリマー組成物のデリバリーシステム |
| US20100081713A1 (en) * | 2008-03-19 | 2010-04-01 | CombinatoRx, (Singapore) Pte. Ltd. | Compositions and methods for treating viral infections |
| HUE047170T2 (hu) * | 2011-05-16 | 2020-04-28 | Starpharma Pty Ltd | Bakteriális vaginózis kezelési vagy megelõzési módszere |
| WO2014043576A1 (en) * | 2012-09-13 | 2014-03-20 | Starpharma Pty Limited | Method of treatment or prophylaxis of infections of the eye |
| MX2018013373A (es) | 2016-05-05 | 2019-06-10 | Starpharma Pty Ltd | Metodo de profilaxis de la infeccion por virus zika. |
| TW202207921A (zh) * | 2020-05-08 | 2022-03-01 | 美商施萬生物製藥研發Ip有限責任公司 | 以二甲基胺基吖呾醯胺化合物治療受冠狀病毒感染的患者之方法 |
| WO2021229533A1 (en) * | 2020-05-14 | 2021-11-18 | Palani Llc | A fatty acid based composition for treatment and/or prevention of enveloped-virus related infections |
-
2021
- 2021-04-14 JP JP2022563209A patent/JP7869752B2/ja active Active
- 2021-04-14 WO PCT/AU2021/050333 patent/WO2021207790A1/en not_active Ceased
- 2021-04-14 GB GB2200278.6A patent/GB2605247B/en active Active
- 2021-04-14 AU AU2021204697A patent/AU2021204697B1/en active Active
- 2021-04-14 US US17/919,155 patent/US20230330134A1/en active Pending
- 2021-04-14 CN CN202180042050.4A patent/CN116056714A/zh active Pending
- 2021-04-14 EP EP21773258.5A patent/EP3930730A4/en active Pending
- 2021-04-14 GB GBGB2312563.6A patent/GB202312563D0/en not_active Ceased
- 2021-04-14 GB GB2113898.7A patent/GB2599799B/en active Active
- 2021-04-14 SG SG11202112332VA patent/SG11202112332VA/en unknown
- 2021-12-23 AU AU2021290329A patent/AU2021290329B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7802365B2 (ja) | ハンタウイルス感染症の処置のためのmek阻害剤 | |
| CN111228275B (zh) | 一种化合物在制备治疗病毒性肺炎药物中的应用 | |
| CN115697382A (zh) | 具有抗病毒作用的口服使用的乳铁蛋白 | |
| EP2903608B1 (en) | Pharmaceutical composition comprising propionic acid for use in the treatment of viral infections | |
| AU2024278473A1 (en) | Use of sugar cane extracts in the treatment or prevention of microbial infections and dysbiosis | |
| CN111249454A (zh) | 灭活卡介苗在预防或治疗新冠病毒相关病况中的用途 | |
| EP2606898A1 (en) | Composition comprising ligustroflavone, rhoifolin and hyperin, and use thereof in the preparation of a medicament | |
| GB2599799A (en) | Method of prophylaxis of Coronavirus and/or respiratory syncytial virus infection | |
| CN101906122B (zh) | 野漆树苷的提取方法及其制备药物用途 | |
| JP2011157375A5 (cg-RX-API-DMAC10.html) | ||
| CN116459295A (zh) | 一种肺炎清化方及其应用 | |
| CN113855685A (zh) | 糖皮质激素在制备治疗和/或预防呼吸道病毒感染的药物中的用途 | |
| JP2010528053A (ja) | インフルエンザ感染症を治療するための物質および方法 | |
| CN121712513A (zh) | 包含黄原胶或褐藻多糖的用于抗流感病毒的组合物 | |
| CN101432002B (zh) | 治疗慢性阻塞性肺疾病的方法和组合物 | |
| CN102633850A (zh) | 野漆树苷的提取方法及其制备药物用途 | |
| CN105496992A (zh) | 氨溴索沙丁胺醇脂质固体分散体 | |
| CN104721221B (zh) | 琼枝麒麟菜多糖用于制备抗呼吸道病毒药物中的用途 | |
| Singh | Potential role of Curcumin against viral infections with a view on structure and pathogenesis of COVID-19 | |
| WO2024120452A1 (en) | Compositions and methods for prophylaxis and treatment of covid-19 | |
| RU2824607C2 (ru) | 2-(имидазол-4-ил)-этанамид пентандиовой-1,5 кислоты или его фармацевтически приемлемая соль для лечения covid-19 и ее симптомов | |
| WO2021211792A1 (en) | Treatment of coronavirus infections with auranofin | |
| CN105434631A (zh) | 花椒精油在制备用于预防和/或治疗病毒性流感的药物或保健品中的应用 | |
| US11780871B1 (en) | COVID-19 treatment and methods | |
| CN105362226B (zh) | 氨溴索沙丁胺醇气雾剂的制备方法 |